Jianhui Ma
7PUBLICATIONS
41CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Dec 12, 2025
The Selective Estrogen Receptor Degrader ZN-c5 Has Broad Antitumor Activity in Wild-Type and Mutant ER-Positive Breast Cancer Models.Jianhui Ma, Sayee Hegde, Masha Sergeeva
|Jul 14, 2025
Discovery of ZN-c5, an Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) with Improved Pharmacokinetics.Sayee G Hegde, Peter Q Huang, Kevin D Bunker
|May 20, 2025
Discovery of an Orally Bioavailable and Brain Penetrant Selective Estrogen Receptor Degrader.Guobao Zhang, Peter Q Huang, Kevin D Bunker
|Apr 15, 2025
Azenosertib Is a Potent and Selective WEE1 Kinase Inhibitor with Broad Antitumor Activity Across a Range of Solid Tumors.Jianhui Ma, Wen Liu, Jiali Li
|Jan 14, 2025
The Selective WEE1 Inhibitor Azenosertib Shows Synergistic Antitumor Activity with KRASG12C Inhibitors in Preclinical Models.Nathan M Jameson, Daehwan Kim, Catherine Lee
|Jan 04, 2025
Cyclin E1/CDK2 activation defines a key vulnerability to WEE1 kinase inhibition in gynecological cancers.Daehwan Kim, Heekyung Chung, Wen Liu
Pageof 2
Frequent Collaborators
4 joint publications
Kevin D Bunker
3 joint publications
Mark R Lackner
2 joint publications
Nathan M Jameson
2 joint publications
Ahmed A Samatar
2 joint publications
Daehwan Kim
2 joint publications
Sayee Hegde
2 joint publications
Olivier Harismendy
1 joint publications
Alison Parisian
1 joint publications
Fernando Doñate
1 joint publications
Funda Meric-Bernstam
